tiprankstipranks
Trending News
More News >
Advertisement

FLOW - ETF AI Analysis

Compare

Top Page

FLOW

Global X U.S. Cash Flow Kings 100 ETF (FLOW)

Rating:69Neutral
Price Target:
FLOW, the Global X U.S. Cash Flow Kings 100 ETF, has a solid overall rating that reflects a portfolio tilted toward companies with strong cash generation, reasonable valuations, and supportive technical trends. Standout holdings like Diamondback Energy, Devon Energy, Bristol-Myers Squibb, Biogen, and Comcast contribute positively through robust financial performance, strategic growth initiatives, and generally favorable market sentiment. Some positions such as Altria, ADM, Cardinal Health, and DR Horton face headwinds like revenue or margin pressures, leverage, or weaker technical signals, and the fund’s meaningful exposure to energy and a handful of large positions adds sector and concentration risk that can increase volatility.
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Archer Daniels Midland, Altria, and DR Horton, have shown strong year-to-date gains, helping support the fund’s overall results.
Broad Sector Diversification
The ETF spreads its investments across many sectors, including consumer cyclical, technology, health care, energy, and others, which helps reduce reliance on any single industry.
Moderate Expense Ratio
The fund’s expense ratio is relatively moderate for an actively targeted strategy, so fees are not excessively eating into potential returns.
Negative Factors
Recent Weak Short-Term Performance
The ETF has shown weak returns over the past month and slightly negative performance year-to-date, which may concern investors looking for near-term strength.
Heavy U.S. Concentration
With almost all assets invested in U.S. companies and only a small slice in Canada, the fund offers limited geographic diversification and is highly tied to the U.S. market.
Some Lagging Top Holdings
A few key positions, such as Fox and Diamondback, have posted weak year-to-date results, which can drag on the fund’s overall performance.

FLOW vs. SPDR S&P 500 ETF (SPY)

FLOW Summary

The Global X U.S. Cash Flow Kings 100 ETF (FLOW) tracks the Global X U.S. Cash Flow Kings 100 Index, focusing on 100 U.S. companies that generate strong, steady cash flow. It holds a mix of businesses across many sectors, including consumer, technology, energy, and health care. Well-known names include Ford Motor and Accenture. Someone might invest in FLOW to get broad exposure to financially solid companies that may be better able to handle economic ups and downs. A key risk is that the ETF still moves with the stock market, so its value can go up and down over time.
How much will it cost me?The Global X U.S. Cash Flow Kings 100 ETF (FLOW) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This is lower than average for actively managed ETFs, as it focuses on a specific strategy targeting companies with strong cash flow metrics while keeping costs relatively affordable.
What would affect this ETF?The Global X U.S. Cash Flow Kings 100 ETF (FLOW) could benefit from strong economic growth in the U.S., particularly in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns could negatively impact cash flow generation for companies in these sectors, while regulatory changes in industries like healthcare or energy might also pose risks. The ETF’s focus on financially resilient companies may help mitigate some of these challenges over time.

FLOW Top 10 Holdings

FLOW leans into U.S. cash-generating workhorses, with energy names like Devon Energy and Diamondback setting the pace as they ride strong momentum and healthy balance sheets. Defensive staples such as Altria and Archer Daniels Midland are more steady contributors, helping smooth out bumps when markets get jumpy. On the health care side, Bristol-Myers Squibb and Cardinal Health are rising but still wrestling with debt and valuation worries, so they’re not all-out heroes yet. Overall, the fund is firmly U.S.-focused, with a tilt toward energy, consumer, and health care cash-flow machines.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Devon Energy2.46%$718.77K$27.87B31.24%
79
Outperform
Altria Group2.41%$703.52K$114.84B22.01%
64
Neutral
Diamondback2.38%$695.45K$50.48B23.39%
81
Outperform
Archer Daniels Midland2.37%$692.82K$33.50B51.92%
64
Neutral
Bristol-Myers Squibb2.33%$681.14K$126.95B4.88%
78
Outperform
Cardinal Health2.29%$668.43K$54.09B77.95%
66
Neutral
DR Horton2.21%$644.93K$44.73B22.85%
66
Neutral
Biogen2.19%$641.25K$27.60B31.83%
74
Outperform
APA2.14%$626.26K$11.19B67.76%
73
Outperform
Ford Motor2.12%$619.00K$53.42B46.82%
71
Outperform

FLOW Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
36.52
Negative
100DMA
35.55
Positive
200DMA
33.96
Positive
Market Momentum
MACD
-0.05
Positive
RSI
45.06
Neutral
STOCH
26.45
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLOW, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 36.63, equal to the 50-day MA of 36.52, and equal to the 200-day MA of 33.96, indicating a neutral trend. The MACD of -0.05 indicates Positive momentum. The RSI at 45.06 is Neutral, neither overbought nor oversold. The STOCH value of 26.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FLOW.

FLOW Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$29.06M0.25%
69
Neutral
$99.79M0.89%
69
Neutral
$99.18M0.45%
75
Outperform
$96.85M0.75%
69
Neutral
$96.19M0.80%
70
Outperform
$95.15M0.85%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FLOW
Global X U.S. Cash Flow Kings 100 ETF
36.11
5.96
19.77%
BAMD
Brookstone Dividend Stock ETF
FMTM
MarketDesk Focused U.S. Momentum ETF
SOVF
Sovereign's Capital Flourish Fund
FFTY
Innovator IBD 50 ETF
STNC
Stance Equity ESG Large Cap Core ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement